Design of orally bioavailable, symmetry-based inhibitors of HIV protease

Dale J. Kempf, Kennan C. Marsh, Lynnmarie Codacovi Fino, Pamela Bryant, Adrienne Craig-Kennard, Hing L. Sham, Chen Zhao, Sudthida Vasavanonda, William E. Kohlbrenner, Norman E. Wideburg, Ayda Saldivar, Brian E. Green, Thomas Herrin, Daniel W. Norbeck

Open source

DOI
10.1016/s0968-0896(00)82036-2
Published
1994-09
Container
Bioorganic & Medicinal Chemistry
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0968-0896-00-82036-2,
  title = {Design of orally bioavailable, symmetry-based inhibitors of HIV protease},
  author = {Dale J. Kempf and Kennan C. Marsh and Lynnmarie Codacovi Fino and Pamela Bryant and Adrienne Craig-Kennard and Hing L. Sham and Chen Zhao and Sudthida Vasavanonda and William E. Kohlbrenner and Norman E. Wideburg and Ayda Saldivar and Brian E. Green and Thomas Herrin and Daniel W. Norbeck},
  year = {1994},
  journal = {Bioorganic \& Medicinal Chemistry},
  doi = {10.1016/s0968-0896(00)82036-2},
  url = {https://doi.org/10.1016/s0968-0896(00)82036-2}
}

RIS

TY  - JOUR
TI  - Design of orally bioavailable, symmetry-based inhibitors of HIV protease
AU  - Dale J. Kempf
AU  - Kennan C. Marsh
AU  - Lynnmarie Codacovi Fino
AU  - Pamela Bryant
AU  - Adrienne Craig-Kennard
AU  - Hing L. Sham
AU  - Chen Zhao
AU  - Sudthida Vasavanonda
AU  - William E. Kohlbrenner
AU  - Norman E. Wideburg
AU  - Ayda Saldivar
AU  - Brian E. Green
AU  - Thomas Herrin
AU  - Daniel W. Norbeck
PY  - 1994
JO  - Bioorganic & Medicinal Chemistry
DO  - 10.1016/s0968-0896(00)82036-2
UR  - https://doi.org/10.1016/s0968-0896(00)82036-2
ER  - 

APA

Kempf, D. J., Marsh, K. C., Fino, L. C., Bryant, P., Craig-Kennard, A., Sham, H. L., Zhao, C., Vasavanonda, S., Kohlbrenner, W. E., Wideburg, N. E., Saldivar, A., Green, B. E., Herrin, T., & Norbeck, D. W. (1994). Design of orally bioavailable, symmetry-based inhibitors of HIV protease. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/s0968-0896(00)82036-2

Source records